Yuedong Li
Corporate Officer/Principal chez Peking University
Profil
Dr. Yuedong Li is Deputy Director-Center for Organ Transplants at Peking University and Chief Secretary at Chinese Hospital Association.
He is on the Board of Directors at China Medical Technologies, Inc.
He received his undergraduate degree from Peking University.
Postes actifs de Yuedong Li
Sociétés | Poste | Début |
---|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/10/2006 |
Chinese Hospital Association | Secrétaire Général | - |
Anciens postes connus de Yuedong Li
Sociétés | Poste | Fin |
---|---|---|
China Medical Technologies, Inc.
China Medical Technologies, Inc. Medical SpecialtiesHealth Technology China Medical Technologies, Inc. is a China-based medical device company. It develops, manufactures and markets vitro diagnostic products using enhanced chemiluminescence technology, fluorescent in situ hybridization technology and surface plasmon resonance technology to detect and monitor various diseases and disorders. The company was founded in July 1999 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - |
Formation de Yuedong Li
Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
China Medical Technologies, Inc.
China Medical Technologies, Inc. Medical SpecialtiesHealth Technology China Medical Technologies, Inc. is a China-based medical device company. It develops, manufactures and markets vitro diagnostic products using enhanced chemiluminescence technology, fluorescent in situ hybridization technology and surface plasmon resonance technology to detect and monitor various diseases and disorders. The company was founded in July 1999 and is headquartered in Beijing, China. | Health Technology |
Chinese Hospital Association |